GL1X · GenesisL1 explorer

MolNFT v1 · #189694 · protein

Crystal structure of human serum albumin complex with aripiprazole and myristic acid

7VR9: “Crystal structure of human serum albumin complex with aripiprazole and myristic acid”. X-ray diffraction, 2 ligands (MYR, 9SC), 15 pockets (best druggability 0.88). MolNFT v1 #189694 on GenesisL1: 3D structure, binding sites and…

PDB
7VR9
Type
protein
Length
1,156 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Serum albumin
UniProt
P02768
Ligands
MYR, 9SC
Pockets
15 · best druggability 0.88

Structure

x-ray diffraction · 2 distinct chains · 72% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASerum albuminprotein57871% helix, 0% strandP02768
BSerum albuminprotein57872% helix, 0% strandP02768

Ligands and binding sites

  • MYR · Myristic acid · ligand · 12 copies · chains A, B
  • 9SC · 7-[4-[4-[2,3-bis(chloranyl)phenyl]piperazin-1-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

15 pockets found on a 1 Å grid, 10 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111950.880.89114MYR
211470.880.89121MYR
33480.800.9043MYR
43620.780.8843MYR
54090.760.85379SC

Interfaces

1 interface between chains.

  • A–B · 282 Ų buried · 4 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 34 disulfide (disulfide).

Compared structures

  • 7VR9 · Crystal structure of human serum albumin complex with aripiprazole and myristic acid · the same entry in another collection · chain A against A, TM-score 1.00
  • P02768 · AlphaFold monomer V2.0 prediction for albumin (P02768) · a predicted model of the same protein · chain B against A, TM-score 0.86

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.